Skip to research content
Filings
/

Filing A003B156-2

Filing A003B156-2

FI

Published 6 Mar 2024

Effective
Back to XSpray Pharma AB (publ)

ModificationEffective

Summary

USD

Amounts are shown in their original currency. Calculated values are marked beside each transaction, with the original table values when the execution price comes from comments.

Amounts in USD

Net disclosed value
US$19,900.00
Transactions
1
Purchase value
US$19,900.00
Sale value
US$0.00
Total disclosed value
US$19,900.00
Other reported value
US$0.00

Includes 1 value calculated from quantity × unit price.

Transactions

0

All disclosed operations, including compensation and transfers. Values can represent transferred assets rather than cash invested.